Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease

Diane Armao, Rachel M. Bailey, Thomas W. Bouldin, Yongbaek Kim, Steven J. Gray

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Giant axonal neuropathy (GAN) is an inherited severe sensorimotor neuropathy. The aim of this research was to investigate the neuropathologic features and clinical autonomic nervous system (ANS) phenotype in two GAN knockout (KO) mouse models. Little is known about ANS involvement in GAN in humans, but autonomic signs and symptoms are commonly reported in early childhood. Methods: Routine histology and immunohistochemistry was performed on GAN KO mouse specimens taken at various ages. Enteric dysfunction was assessed by quantifying the frequency, weight, and water content of defecation in GAN KO mice. Results: Histological examination of the enteric, parasympathetic and sympathetic ANS of GAN KO mice revealed pronounced and widespread neuronal perikaryal intermediate filament inclusions. These neuronal inclusions served as an easily identifiable, early marker of GAN in young GAN KO mice. Functional studies identified an age-dependent alteration in fecal weight and defecation frequency in GAN KO mice. Conclusions: For the first time in the GAN KO mouse model, we described the early, pronounced and widespread neuropathologic features involving the ANS. In addition, we provided evidence for a clinical autonomic phenotype in GAN KO mice, reflected in abnormal gastrointestinal function. These findings in GAN KO mice suggest that consideration should be given to ANS involvement in human GAN, especially when considering treatments and patient care.

Original languageEnglish (US)
Pages (from-to)307-313
Number of pages7
JournalClinical Autonomic Research
Volume26
Issue number4
DOIs
StatePublished - Aug 1 2016

Fingerprint

Giant Axonal Neuropathy
Autonomic Nervous System
Knockout Mice
Defecation
Phenotype
Weights and Measures
Intermediate Filaments

Keywords

  • Autonomic nervous system
  • Giant axonal neuropathy
  • Gigaxonin
  • Intermediate filaments
  • Neurodegenerative disease

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Clinical Neurology

Cite this

Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse : implications for human disease. / Armao, Diane; Bailey, Rachel M.; Bouldin, Thomas W.; Kim, Yongbaek; Gray, Steven J.

In: Clinical Autonomic Research, Vol. 26, No. 4, 01.08.2016, p. 307-313.

Research output: Contribution to journalArticle

Armao, Diane ; Bailey, Rachel M. ; Bouldin, Thomas W. ; Kim, Yongbaek ; Gray, Steven J. / Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse : implications for human disease. In: Clinical Autonomic Research. 2016 ; Vol. 26, No. 4. pp. 307-313.
@article{4ccf0d49d6e742e78381f7a48ad6606e,
title = "Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse: implications for human disease",
abstract = "Purpose: Giant axonal neuropathy (GAN) is an inherited severe sensorimotor neuropathy. The aim of this research was to investigate the neuropathologic features and clinical autonomic nervous system (ANS) phenotype in two GAN knockout (KO) mouse models. Little is known about ANS involvement in GAN in humans, but autonomic signs and symptoms are commonly reported in early childhood. Methods: Routine histology and immunohistochemistry was performed on GAN KO mouse specimens taken at various ages. Enteric dysfunction was assessed by quantifying the frequency, weight, and water content of defecation in GAN KO mice. Results: Histological examination of the enteric, parasympathetic and sympathetic ANS of GAN KO mice revealed pronounced and widespread neuronal perikaryal intermediate filament inclusions. These neuronal inclusions served as an easily identifiable, early marker of GAN in young GAN KO mice. Functional studies identified an age-dependent alteration in fecal weight and defecation frequency in GAN KO mice. Conclusions: For the first time in the GAN KO mouse model, we described the early, pronounced and widespread neuropathologic features involving the ANS. In addition, we provided evidence for a clinical autonomic phenotype in GAN KO mice, reflected in abnormal gastrointestinal function. These findings in GAN KO mice suggest that consideration should be given to ANS involvement in human GAN, especially when considering treatments and patient care.",
keywords = "Autonomic nervous system, Giant axonal neuropathy, Gigaxonin, Intermediate filaments, Neurodegenerative disease",
author = "Diane Armao and Bailey, {Rachel M.} and Bouldin, {Thomas W.} and Yongbaek Kim and Gray, {Steven J.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s10286-016-0365-7",
language = "English (US)",
volume = "26",
pages = "307--313",
journal = "Clinical Autonomic Research",
issn = "0959-9851",
publisher = "D. Steinkopff-Verlag",
number = "4",

}

TY - JOUR

T1 - Autonomic nervous system involvement in the giant axonal neuropathy (GAN) KO mouse

T2 - implications for human disease

AU - Armao, Diane

AU - Bailey, Rachel M.

AU - Bouldin, Thomas W.

AU - Kim, Yongbaek

AU - Gray, Steven J.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Purpose: Giant axonal neuropathy (GAN) is an inherited severe sensorimotor neuropathy. The aim of this research was to investigate the neuropathologic features and clinical autonomic nervous system (ANS) phenotype in two GAN knockout (KO) mouse models. Little is known about ANS involvement in GAN in humans, but autonomic signs and symptoms are commonly reported in early childhood. Methods: Routine histology and immunohistochemistry was performed on GAN KO mouse specimens taken at various ages. Enteric dysfunction was assessed by quantifying the frequency, weight, and water content of defecation in GAN KO mice. Results: Histological examination of the enteric, parasympathetic and sympathetic ANS of GAN KO mice revealed pronounced and widespread neuronal perikaryal intermediate filament inclusions. These neuronal inclusions served as an easily identifiable, early marker of GAN in young GAN KO mice. Functional studies identified an age-dependent alteration in fecal weight and defecation frequency in GAN KO mice. Conclusions: For the first time in the GAN KO mouse model, we described the early, pronounced and widespread neuropathologic features involving the ANS. In addition, we provided evidence for a clinical autonomic phenotype in GAN KO mice, reflected in abnormal gastrointestinal function. These findings in GAN KO mice suggest that consideration should be given to ANS involvement in human GAN, especially when considering treatments and patient care.

AB - Purpose: Giant axonal neuropathy (GAN) is an inherited severe sensorimotor neuropathy. The aim of this research was to investigate the neuropathologic features and clinical autonomic nervous system (ANS) phenotype in two GAN knockout (KO) mouse models. Little is known about ANS involvement in GAN in humans, but autonomic signs and symptoms are commonly reported in early childhood. Methods: Routine histology and immunohistochemistry was performed on GAN KO mouse specimens taken at various ages. Enteric dysfunction was assessed by quantifying the frequency, weight, and water content of defecation in GAN KO mice. Results: Histological examination of the enteric, parasympathetic and sympathetic ANS of GAN KO mice revealed pronounced and widespread neuronal perikaryal intermediate filament inclusions. These neuronal inclusions served as an easily identifiable, early marker of GAN in young GAN KO mice. Functional studies identified an age-dependent alteration in fecal weight and defecation frequency in GAN KO mice. Conclusions: For the first time in the GAN KO mouse model, we described the early, pronounced and widespread neuropathologic features involving the ANS. In addition, we provided evidence for a clinical autonomic phenotype in GAN KO mice, reflected in abnormal gastrointestinal function. These findings in GAN KO mice suggest that consideration should be given to ANS involvement in human GAN, especially when considering treatments and patient care.

KW - Autonomic nervous system

KW - Giant axonal neuropathy

KW - Gigaxonin

KW - Intermediate filaments

KW - Neurodegenerative disease

UR - http://www.scopus.com/inward/record.url?scp=84976512768&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84976512768&partnerID=8YFLogxK

U2 - 10.1007/s10286-016-0365-7

DO - 10.1007/s10286-016-0365-7

M3 - Article

C2 - 27369358

AN - SCOPUS:84976512768

VL - 26

SP - 307

EP - 313

JO - Clinical Autonomic Research

JF - Clinical Autonomic Research

SN - 0959-9851

IS - 4

ER -